GSK plc Reports Transactions in Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Jun 25, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, company-filing
TL;DR
GSK buying back its own stock, filing shows.
AI Summary
GSK plc announced on June 25, 2025, that it has conducted transactions in its own shares. The company is acting through its corporate stockbroker to manage these transactions, which are detailed in this Form 6-K filing.
Why It Matters
This filing indicates GSK's activity in managing its share capital, which can impact share price and investor perception.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of share transactions and does not present new material risks.
Key Players & Entities
- GSK plc (company) — Registrant
- 001-15170 (company) — SEC File Number
- 20250625 (date) — Filing Date
FAQ
What type of transaction is GSK plc reporting?
GSK plc is reporting transactions in its own shares.
What is the filing date of this report?
The filing date is June 25, 2025.
What is the SEC file number for GSK plc?
The SEC file number for GSK plc is 001-15170.
Under which rule is this report filed?
This report is filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Does GSK plc file annual reports under Form 20-F or 40-F?
GSK plc indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 25, 2025 regarding GSK plc (GLAXF).